Loading provider…
Loading provider…
Hematology & Oncology Physician in Fargo, ND
NPI: 1013935667Primary Practice Location
SANFORD MEDICAL CENTER FARGO
801 Broadway N, Fargo, ND
Primary Employer
Sanford Medical Center - Cavalier
sanfordhealth.org
HQ Phone
Get MD Gerald's Phone Numberphone_androidMobile
Get MD Gerald's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardND State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 147 | 387 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 87 | 146 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 43 | 130 |
| 4 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 38 | 124 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 20 | 28 |
Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903).
Authors: Olga Frankfurt, Natalie Callander, Martin Tallman, Gordon Srkalovic, David Claxton
Publication Date: 2019-03-10
Authors: Karthik Giridhar, Winston Tan, Edith Perez, Alvaro Moreno-Aspitia, Rex Mowat, Richard Tenglin, Kostandinos Sideras
Journal: Oncologist
Publication Date: 2022-04-21
Authors: Mark Sborov, Michael Cannon, Philip Stella, Aminah Jatoi, Robert Behrens, Kendrith Rowland
Journal: Cancer Invest
Publication Date: 2011-02-23
Lead Sponsor: Washington University School of Medicine
Collaborators: Celgene Corporation
Intervention / Treatment: DRUG: Carboplatin, BIOLOGICAL: Cetuximab, DRUG: Cisplatin, DRUG: nab-paclitaxel